Format

Send to

Choose Destination
See comment in PubMed Commons below
PLoS One. 2012;7(5):e37955. doi: 10.1371/journal.pone.0037955. Epub 2012 May 23.

Propentofylline targets TROY, a novel microglial signaling pathway.

Author information

1
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire, United States of America.

Erratum in

  • PLoS One. 2013;8(1). doi:10.1371/annotation/d8f0ef0f-414e-49aa-92a8-fd8d838b611b.

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain cancer, with a median survival of less than 2 years after diagnosis with current available therapies. The tumor microenvironment serves a critical role in tumor invasion and progression, with microglia as a critical player. Our laboratory has previously demonstrated that propentofylline, an atypical methylxanthine with central nervous system glial modulating and anti-inflammatory actions, significantly decreases tumor growth in a GBM rodent model by preferentially targeting microglia. In the present study, we used the CNS-1 rat glioma model to elucidate the mechanisms of propentofylline. Here we demonstrate that propentofylline targets TROY, a novel signaling molecule up-regulated in infiltrating microglia, and not macrophages, in response to CNS-1 cells. We identify Pyk2, Rac1 and pJNK as the downstream signaling molecules of TROY through western blot analysis and siRNA transfection. We demonstrate that inhibition of TROY expression in microglia by siRNA transfection significantly inhibits microglial migration towards CNS-1 cells similar to 10 µM propentofylline treatment. These results identify TROY as a novel molecule expressed in microglia, involved in their migration and targeted by propentofylline. Furthermore, these results describe a signaling molecule that is differentially expressed between microglia and macrophages in the tumor microenvironment.

PMID:
22649568
PMCID:
PMC3359343
DOI:
10.1371/journal.pone.0037955
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Support Center